• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清表面活性剂 SP-D 与囊性纤维化患者的肺功能呈负相关。

Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis.

机构信息

Department of Pediatrics, Aarhus University Hospital, Skejby, 8200 Arhus N, Denmark.

出版信息

J Cyst Fibros. 2010 Jul;9(4):257-62. doi: 10.1016/j.jcf.2010.03.011. Epub 2010 May 8.

DOI:10.1016/j.jcf.2010.03.011
PMID:20457545
Abstract

BACKGROUND

Cystic fibrosis (CF) affects the lungs causing infections and inflammation. Surfactant protein D (SP-D) is an innate defense lectin primarily secreted in the lungs. We investigated the influence of the SP-D Met11Thr polymorphism on CF lung function; and serum SP-D as a marker for CF lung disease.

METHODS

For 107 CF patients (73 children, and 34 adults) serum SP-D and SP-D Met11Thr genotype were available. Leukocyte count was obtained for a subset of patients. Lung function was measured as forced expiratory volume in one second (FEV-1).

RESULTS

Serum SP-D was increased in CF patients compared to healthy controls, positively correlated to leukocyte count, and negatively correlated to FEV-1. We found no correlation between SP-D Met11Thr genotype and FEV-1, and we found corresponding genotype frequencies in CF patients and in healthy controls.

CONCLUSION

Serum SP-D in CF patients was increased in parallel with leukocyte count and with reduced FEV-1 and may constitute an alternative biomarker for lung disease, in the clinical setting and in research.

摘要

背景

囊性纤维化(CF)会影响肺部,导致感染和炎症。表面活性蛋白 D(SP-D)是一种主要在肺部分泌的先天防御凝集素。我们研究了 SP-D Met11Thr 多态性对 CF 肺功能的影响;以及血清 SP-D 作为 CF 肺疾病的标志物。

方法

我们对 107 名 CF 患者(73 名儿童和 34 名成人)的血清 SP-D 和 SP-D Met11Thr 基因型进行了检测。还对一部分患者进行了白细胞计数。肺功能通过一秒用力呼气量(FEV-1)来测量。

结果

与健康对照组相比,CF 患者的血清 SP-D 升高,与白细胞计数呈正相关,与 FEV-1 呈负相关。我们发现 SP-D Met11Thr 基因型与 FEV-1 之间没有相关性,并且在 CF 患者和健康对照组中发现了相应的基因型频率。

结论

CF 患者的血清 SP-D 与白细胞计数平行升高,与 FEV-1 降低相关,可能是临床和研究中肺疾病的替代生物标志物。

相似文献

1
Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis.血清表面活性剂 SP-D 与囊性纤维化患者的肺功能呈负相关。
J Cyst Fibros. 2010 Jul;9(4):257-62. doi: 10.1016/j.jcf.2010.03.011. Epub 2010 May 8.
2
Increased plasma concentration of surfactant protein D in chronic periodontitis independent of SFTPD genotype: potential role as a biomarker.慢性牙周炎患者血浆中表面活性蛋白D浓度升高,与SFTPD基因型无关:作为生物标志物的潜在作用
Tissue Antigens. 2008 Jul;72(1):21-8. doi: 10.1111/j.1399-0039.2008.01056.x. Epub 2008 May 20.
3
Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis.呼气一氧化氮水平低与囊性纤维化患者的肺功能受损有关。
Pediatr Pulmonol. 2010 Mar;45(3):241-8. doi: 10.1002/ppul.21137.
4
Circulating surfactant protein D is decreased in systemic lupus erythematosus.循环表面活性剂蛋白 D 在系统性红斑狼疮中减少。
J Rheumatol. 2009 Nov;36(11):2449-53. doi: 10.3899/jrheum.090069. Epub 2009 Oct 15.
5
Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.诱导痰基质金属蛋白酶-9与囊性纤维化患儿的肺功能及气道炎症相关。
Pediatr Pulmonol. 2005 Mar;39(3):224-32. doi: 10.1002/ppul.20165.
6
Circulating surfactant protein D is decreased in early rheumatoid arthritis: a 1-year prospective study.循环表面活性蛋白D在类风湿关节炎早期减少:一项为期1年的前瞻性研究。
Scand J Immunol. 2008 Jan;67(1):71-6. doi: 10.1111/j.1365-3083.2007.02039.x.
7
Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis.支气管肺泡灌洗液中的表面活性蛋白A和表面活性蛋白D与早期囊性纤维化中的炎症呈负相关。
Am J Respir Crit Care Med. 2003 Sep 15;168(6):685-91. doi: 10.1164/rccm.200301-005OC. Epub 2003 Jun 26.
8
Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.反复加重影响成年囊性纤维化患者的第一秒用力呼气容积(FEV₁)下降。
Respir Med. 2009 Mar;103(3):407-13. doi: 10.1016/j.rmed.2008.09.024. Epub 2008 Nov 22.
9
Serum surfactant protein D is elevated in allergic patients.过敏性患者血清表面活性蛋白D升高。
Clin Exp Allergy. 2004 Dec;34(12):1827-33. doi: 10.1111/j.1365-2222.2004.02083.x.
10
Breathing pattern and chest wall volumes during exercise in patients with cystic fibrosis, pulmonary fibrosis and COPD before and after lung transplantation.肺移植前后囊性纤维化、肺纤维化和 COPD 患者运动时的呼吸模式和胸壁容量。
Thorax. 2010 Sep;65(9):808-14. doi: 10.1136/thx.2009.131409.

引用本文的文献

1
Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease.坦尼司特,一种用于治疗哮喘和慢性阻塞性肺疾病的新型吸入性磷酸二酯酶4抑制剂。
Front Pharmacol. 2021 Nov 23;12:740803. doi: 10.3389/fphar.2021.740803. eCollection 2021.
2
Serum surfactant protein D in COVID-19 is elevated and correlated with disease severity.血清表面活性剂蛋白 D 在 COVID-19 中升高,并与疾病严重程度相关。
BMC Infect Dis. 2021 Aug 3;21(1):737. doi: 10.1186/s12879-021-06447-3.
3
Genetic Association With Acquisition in Cystic Fibrosis: Influence of Surfactant Protein D and Mannose-Binding Lectin.
囊性纤维化中基因与感染的关联:表面活性蛋白D和甘露糖结合凝集素的影响
Front Immunol. 2021 Feb 19;12:587313. doi: 10.3389/fimmu.2021.587313. eCollection 2021.
4
Surfactant protein-D modulation of pulmonary macrophage phenotype is controlled by -nitrosylation.表面活性蛋白-D 通过 - 亚硝化作用调控肺巨噬细胞表型。
Am J Physiol Lung Cell Mol Physiol. 2019 Nov 1;317(5):L539-L549. doi: 10.1152/ajplung.00506.2018. Epub 2019 Aug 14.
5
Genetic Association of Pulmonary Surfactant Protein Genes, SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD With Cystic Fibrosis.肺表面活性蛋白基因 SFTPA1、SFTPA2、SFTPB、SFTPC 和 SFTPD 与囊性纤维化的遗传关联。
Front Immunol. 2018 Oct 2;9:2256. doi: 10.3389/fimmu.2018.02256. eCollection 2018.
6
Surfactant Protein D in Respiratory and Non-Respiratory Diseases.表面活性蛋白D在呼吸道疾病和非呼吸道疾病中的作用
Front Med (Lausanne). 2018 Feb 8;5:18. doi: 10.3389/fmed.2018.00018. eCollection 2018.
7
Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction.囊性纤维化气道分泌物中的游离DNA与气流阻塞相关。
Mediators Inflamm. 2015;2015:408935. doi: 10.1155/2015/408935. Epub 2015 Mar 31.
8
Factors influencing the measurement of plasma/serum surfactant protein D levels by ELISA.影响酶联免疫吸附测定法检测血浆/血清表面活性蛋白D水平的因素
PLoS One. 2014 Nov 3;9(11):e111466. doi: 10.1371/journal.pone.0111466. eCollection 2014.
9
MMP-9 cleaves SP-D and abrogates its innate immune functions in vitro.MMP-9 可切割 SP-D 并使其先天免疫功能丧失体外。
PLoS One. 2012;7(7):e41881. doi: 10.1371/journal.pone.0041881. Epub 2012 Jul 30.
10
The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosis.系统炎症与成年囊性纤维化患者既往住院的关系。
BMC Pulm Med. 2012 Feb 14;12:3. doi: 10.1186/1471-2466-12-3.